WAUD CAPITAL AFFILIATES II, L.L.C. 4
Accession 0000899243-16-029179
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 7:27 PM ET
Size
20.8 KB
Accession
0000899243-16-029179
Insider Transaction Report
- Sale
Common Stock, par value $0.01 per share
2016-09-15$49.24/sh−223,640$11,012,034→ 4,393,780 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2016-09-16$47.74/sh−521,033$24,874,115→ 3,872,747 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2016-09-14$50.19/sh−83,861$4,208,984→ 4,617,420 total(indirect: See footnotes)
- Sale
Common Stock, par value $0.01 per share
2016-09-14$50.19/sh−83,861$4,208,984→ 4,617,420 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2016-09-15$49.24/sh−223,640$11,012,034→ 4,393,780 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2016-09-16$47.74/sh−521,033$24,874,115→ 3,872,747 total(indirect: See footnotes)
- Sale
Common Stock, par value $0.01 per share
2016-09-16$47.74/sh−521,033$24,874,115→ 3,872,747 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2016-09-15$49.24/sh−223,640$11,012,034→ 4,393,780 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2016-09-14$50.19/sh−83,861$4,208,984→ 4,617,420 total(indirect: See footnotes)
- Sale
Common Stock, par value $0.01 per share
2016-09-16$47.74/sh−521,033$24,874,115→ 3,872,747 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2016-09-15$49.24/sh−223,640$11,012,034→ 4,393,780 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2016-09-14$50.19/sh−83,861$4,208,984→ 4,617,420 total(indirect: See footnotes)
- Sale
Common Stock, par value $0.01 per share
2016-09-14$50.19/sh−83,861$4,208,984→ 4,617,420 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2016-09-16$47.74/sh−521,033$24,874,115→ 3,872,747 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2016-09-15$49.24/sh−223,640$11,012,034→ 4,393,780 total(indirect: See footnotes)
- Sale
Common Stock, par value $0.01 per share
2016-09-16$47.74/sh−521,033$24,874,115→ 3,872,747 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2016-09-14$50.19/sh−83,861$4,208,984→ 4,617,420 total(indirect: See footnotes) - Sale
Common Stock, par value $0.01 per share
2016-09-15$49.24/sh−223,640$11,012,034→ 4,393,780 total(indirect: See footnotes)
Footnotes (8)
- [F1]Represents shares sold in multiple transactions under Rule 144 as follows: (i) 15,785 shares by Waud Capital Partners II, L.P. ("WCP II"), (ii) 47,664 shares by Waud Capital Partners QP II, L.P. ("Waud QP II"), (iii) 10,084 shares by WCP FIF II (Acadia), L.P. ("WCP FIF II") and (iv) 10,328 shares by Waud Capital Affiliates II, L.L.C. ("Waud Affiliates II").
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $50.00 to $50.54, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (1) to this Form 4.
- [F3]Reeve B. Waud is a member of the board of directors of Acadia Healthcare Company, Inc. Mr. Waud is also the manager of Waud Capital Partners II, L.L.C. ("Waud II LLC") and a member of the Limited Partner Committee of Waud Capital Partners Management II, L.P. ("WCPM II"). Waud II LLC is the general partner of WCPM II. WCPM II is the general partner of WCP II, Waud QP II and WCP FIF II and the manager of Waud Affiliates II. As a result, each of Mr. Waud, Waud II LLC and WCPM II may be deemed to share beneficial ownership of the reported shares.
- [F4]Represents shares sold in multiple transactions under Rule 144 as follows: (i) 42,095 shares by WCP II, (ii) 127,109 shares by Waud QP II, (iii) 26,893 shares by WCP FIF II and (iv) 27,543 shares by Waud Affiliates II.
- [F5]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $49.00 to $49.67, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (4) to this Form 4.
- [F6]Represents shares sold as follows: (i) 98,073 shares by WCP II, (ii) 296,136 shares by Waud QP II, (iii) 62,655 shares by WCP FIF II and (iv) 64,169 shares by Waud Affiliates II.
- [F7]The reported shares are owned of record as follows: (i) 1,141,420 shares by WCP II, (ii) 2,086,697 shares by Waud QP II, (iii) 318,466 shares by WCP FIF II and (iv) 326,164 shares by Waud Affiliates II.
- [F8]Each of the reporting persons expressly disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest therein.
Documents
Issuer
Acadia Healthcare Company, Inc.
CIK 0001520697
Related Parties
1- filerCIK 0001532464
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 7:27 PM ET
- Size
- 20.8 KB